The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway

PLoS Genet. 2015 Sep 10;11(9):e1005503. doi: 10.1371/journal.pgen.1005503. eCollection 2015 Sep.

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is a key molecule in the pathogenesis of familial and idiopathic Parkinson's disease (PD). We have identified two novel LRRK2-associated proteins, a HECT-type ubiquitin ligase, HERC2, and an adaptor-like protein with six repeated Neuralized domains, NEURL4. LRRK2 binds to NEURL4 and HERC2 via the LRRK2 Ras of complex proteins (ROC) domain and NEURL4, respectively. HERC2 and NEURL4 link LRRK2 to the cellular vesicle transport pathway and Notch signaling, through which the LRRK2 complex promotes the recycling of the Notch ligand Delta-like 1 (Dll1)/Delta (Dl) through the modulation of endosomal trafficking. This process negatively regulates Notch signaling through cis-inhibition by stabilizing Dll1/Dl, which accelerates neural stem cell differentiation and modulates the function and survival of differentiated dopaminergic neurons. These effects are strengthened by the R1441G ROC domain-mutant of LRRK2. These findings suggest that the alteration of Notch signaling in mature neurons is a component of PD etiology linked to LRRK2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier Proteins / metabolism
  • Dopamine / metabolism
  • Drosophila
  • Endosomes / metabolism*
  • Guanine Nucleotide Exchange Factors / metabolism
  • HEK293 Cells
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Parkinson Disease / enzymology*
  • Protein Binding
  • Protein Serine-Threonine Kinases / metabolism
  • Protein Serine-Threonine Kinases / physiology*
  • Receptors, Notch / metabolism*
  • Signal Transduction / physiology*
  • Ubiquitin-Protein Ligases

Substances

  • Carrier Proteins
  • Guanine Nucleotide Exchange Factors
  • Receptors, Notch
  • HERC2 protein, human
  • Neurl4 protein, human
  • Ubiquitin-Protein Ligases
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases
  • Dopamine

Grants and funding

This work was supported by the Grant-in-Aid for Scientific Research 21790302 (YI) from JSP in Japan (https://www.jsps.go.jp/english/e-grants/), the Cell Science Research Foundation (YI)(http://www.shionogi.co.jp/zaidan/), the CREST program of JST in Japan (RT, NH)(http://www.jst.go.jp/kisoken/crest/en/about/basic.html), Grant-in-Aid for Scientific Research on Innovative Areas 23110502, 23110507, 23110518 (YI, RT, NH) from the MEXT in Japan (http://www.tmd.ac.jp/mri/shingakujutu/index-e.html), and Grant-in-Aid for Science Research 201324018A from the MHLW in Japan (RT)(http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.